Literature DB >> 16550051

Clinical features and management of tumors affecting the lacrimal drainage apparatus.

Alejandra A Valenzuela1, Alan A McNab, Dinesh Selva, Brett A O'Donnell, Kevin J Whitehead, Timothy J Sullivan.   

Abstract

PURPOSE: To report the clinical features of a series of patients with lacrimal drainage apparatus tumors and present guidelines for management based on histopathology.
METHODS: A non-comparative retrospective chart review of the clinical, imaging, and pathologic findings of 37 patients presenting to four regional orbital surgery departments with tumors affecting the lacrimal drainage apparatus between 1990 and 2004.
RESULTS: There were 37 patients, of whom 62% were male. The mean age at referral was 54 years. Epiphora, a palpable mass, and dacryocystitis were the most common presentations. Two thirds of the tumors were epithelial, with carcinomas being the most frequent (38%), followed by papillomas (27%). Lymphomas were the most common nonepithelial malignancy (30%). Epithelial tumors were more common in men (87%), whereas lymphomas were more common in women (57%). Treatment modalities included surgery, in addition to radiotherapy and/or chemotherapy and immunotherapy. Mean follow-up was 38 months. Thirty-three patients (89%) remain alive without evidence of disease and 4 patients died of recurrence and/or metastases.
CONCLUSIONS: Lacrimal drainage apparatus tumors require careful initial management to ensure adequate local and systemic disease control. Atypical mucosa encountered during dacryocystorhinostomy should be biopsied and small papillomas or pedunculated tumors excised and analyzed with frozen sections. If a diffuse or infiltrative mass is encountered, it should be biopsied and managed on the basis of histopathology and extent of disease. Lymphomas should be treated according to protocols, whereas noninvasive carcinoma and extensive papillomas require complete excision of the system. Invasive disease requires en bloc excision. Long-term follow-up is essential for early detection of recurrence.

Entities:  

Mesh:

Year:  2006        PMID: 16550051     DOI: 10.1097/01.iop.0000198457.71173.7b

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  14 in total

1.  [Selective lacrimal sac biopsy for external dacryocystorhinostomy: a clinical pathological study].

Authors:  L M Heindl; E Treutlein; A G M Jünemann; F E Kruse; L M Holbach
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

2.  Expect the unexpected.

Authors:  I C Francis; G Wilcsek
Journal:  Br J Ophthalmol       Date:  2006-08       Impact factor: 4.638

3.  A case of recurrent Schneiderian papilloma of the lacrimal sac invading the nasal cavity.

Authors:  Ji Hye Jang; Sung Dong Chang; Mi Sun Choe
Journal:  Korean J Ophthalmol       Date:  2009-06-09

Review 4.  A 7-year prospective study of routine histopathological evaluation of the lacrimal sac wall incisional biopsy specimens obtained during external dacryocystorhinostomy in adults and a review of the literature.

Authors:  Miroslav Knežević; M Stojković; M Jovanović; Z Stanković; Dejan M Rašić
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

5.  [Prolapse of the upper lacrimal punctum].

Authors:  F Bucher; J W U Fries; D Hos; K R Koch; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

Review 6.  Clinical significance of routine lacrimal sac biopsy during dacryocystorhinostomy: A comprehensive review of literature.

Authors:  Zoran Koturović; Miroslav Knežević; Dejan M Rašić
Journal:  Bosn J Basic Med Sci       Date:  2017-02-21       Impact factor: 3.363

7.  Endoscopic surgery for inverted papilloma with carcinoma change of lacrimal drainage apparatus and nasal cavity.

Authors:  Yin-Hung Chang; Tsan-Jen Chiu; Wei-Cherng Hsu
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

8.  Pathological, immunohistochemical and microbiologicalal analysis of lacrimal sac biopsies in patients with chronic dacrocystitis.

Authors:  Rowayda Mahmoud Amin; Faten Aly Hussein; Hisham Farouk Idriss; Nesrine Fathy Hanafy; Dina Mohamed Abdallah
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

9.  Pyogenic granuloma of the lacrimal sac.

Authors:  Bülent Yazici; Ayşe Tör Ayvaz; Sibel Aker
Journal:  Int Ophthalmol       Date:  2007-11-16       Impact factor: 2.031

10.  Unexpected pathologies in patients referred for endoscopic DCR.

Authors:  Shani Golan; Igal Leibovitch; Roee Landsberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.